Literature DB >> 18021227

A case of severe recurrent hepatitis with common variable immunodeficiency.

Koji Fukushima1, Yoshiyuki Ueno, Hirokazu Kanegane, Yoko Yamagiwa, Jun Inoue, Osamu Kido, Futoshi Nagasaki, Takayuki Kogure, Eiji Kakazu, Yu Nakagome, Yasunori Matsuda, Noriyuki Obara, Osamu Kimura, Tooru Shimosegawa.   

Abstract

Severe hepatitis with an indistinct etiology manifested in a 16-year-old boy who had no particular history. The histological features of the liver and clinical course of the patient were similar to those of patients with autoimmune hepatitis characterized by interface hepatitis and severe lobular inflammation of the liver and recurrent exacerbations of hepatitis. We administered intravenous glycyrrhizin preparation daily or three times a week combined with the oral administration of ursodeoxycholic acid daily throughout the term after the initial onset of disease for the control of disease activity. The normalization of the concentration of alanine aminotransferase in serum was achieved in response to the therapy during the course. The serum concentration of immunoglobulins of the patient gradually decreased from the onset of the disease to an unacceptable level without globulin preparation during the following period of 17 months. Immunological tests revealed impairment of immunoglobulin production bythe B cell population of the patient, which led to the diagnosis of the patient as common variable immunodeficiency (CVID). The patient, with improved liver histology after 27 months from the onset of disease, benefited from the current combination therapy without severe infection through the avoidance of overimmunosuppression. CVID is defined as a heterogeneous syndrome characterized by various degrees of hypogammaglobulinemia without any specific predisposing causes, frequently associated with autoimmunity. Diagnostic criteria and therapeutic options of persistent hepatitis with CVID are to be established, as discussed in the current report.

Entities:  

Year:  2007        PMID: 18021227     DOI: 10.1111/j.1872-034X.2007.00281.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

1.  A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID).

Authors:  Kaushang Gandhi; Purvi Parikh; Wilbert S Aronow; Harit Desai; Harshad Amin; Mala Sharma; Arye Rubinstein
Journal:  J Gastrointest Cancer       Date:  2010-12

Review 2.  Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

Review 3.  Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 4.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 5.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 6.  State-of-the-art diagnostic evaluation of common variable immunodeficiency.

Authors:  Theodore K Lee; Jessica D Gereige; Paul J Maglione
Journal:  Ann Allergy Asthma Immunol       Date:  2021-03-11       Impact factor: 6.248

7.  Severe Aplastic Anemia following Acute Hepatitis from Toxic Liver Injury: Literature Review and Case Report of a Successful Outcome.

Authors:  Kamran Qureshi; Usman Sarwar; Hicham Khallafi
Journal:  Case Reports Hepatol       Date:  2014-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.